Vitamin D supplements compared with placebo (a sham treatment) may slightly reduce the number of young children who need a doctor or hospital visit for sudden infections in the lungs and airways ...

‘Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease’ was published in the Cochrane Database of Systematic Reviews at ...

Seventeen placebo-controlled trials across seven antibodies yielded statistically significant but clinically small mean ...

Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing ...

Drinking antioxidant-rich cranberry juice may prevent urinary tract infections, support gut health, and manage arthritis.

Retinopathy of prematurity is a common disease in babies born prematurely with a birth weight less than 1500 grams. It is caused when blood vessels in the back of the eye do not grow normally.

For adults with mild cognitive impairment (MCI) or mild dementia due to Alzheimer disease, amyloid-beta-targeted monoclonal ...

Anti-amyloid drugs likely provide no "clinically meaningful" effects for people with Alzheimer's, the authors concluded.

Anti-amyloid drugs may not have a clinically meaningful effect in the treatment of Alzheimer's disease, a new review says. So ...

In certain instances, the research indicated that nurse-led care demonstrated superior outcomes than doctor-led care. The ...

Amyloid-beta-targeted monoclonal antibodies probably resulted in little to no difference in cognitive function or in dementia severity.

Despite reducing amyloid plaques, antibody treatments for Alzheimer's fail to improve cognition, highlighting critical gaps ...